A pneumococcal vaccine combination with two proteins containing PspA families 1 and 2 can potentially protect against a wide range of Streptococcus pneumoniae strains

Protective properties of a fusion pneumococcal surface protein A (PspA) vaccine against pneumococcal challenge by five different PspA clades in mice

(2014) Zhenyu Piao et al.   VACCINE

Current status and perspectives on protein-based pneumococcal vaccines

(2013) Michelle Darrieux et al.   CRITICAL REVIEWS IN MICROBIOLOGY

Ten years of experience with the pneumococcal conjugate 7-valent vaccine in children

(2013) C. Weil Olivier   MEDECINE ET MALADIES INFECTIEUSES

Serotype-independent pneumococcal vaccines

(2012) Eliane Namie Miyaji et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

The Absence of PspA or Presence of Antibody to PspA Facilitates the Complement-Dependent Phagocytosis of PneumococciIn Vitro

(2012) Bing Ren et al.   Clinical and Vaccine Immunology

Monitoring the Long-Term Molecular Epidemiology of the Pneumococcus and Detection of Potential ‘Vaccine Escape’ Strains

(2011) Gagan A. Pandya et al.   PLoS One

The future of pneumococcal disease prevention

(2011) Gail L. Rodgers et al.   VACCINE

Immunization of Mice with Single PspA Fragments Induces Antibodies Capable of Mediating Complement Deposition on Different Pneumococcal Strains and Cross-Protection

(2010) A. T. Moreno et al.   Clinical and Vaccine Immunology

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

(2009) Katherine L O'Brien et al.   LANCET

Development of Antibodies to PspA Families 1 and 2 in Children after Exposure to Streptococcus pneumoniae

(2008) M. M. Melin et al.   Clinical and Vaccine Immunology

Recognition of pneumococcal isolates by antisera raised against PspA fragments from different clades

(2008) M. Darrieux et al.   JOURNAL OF MEDICAL MICROBIOLOGY